Lanean...
Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
Eslicarbazepine acetate (ESL) is a once daily new third generation antiepileptic drug that shares the basic chemical structure of carbamazepine and oxcarbazepine – a dibenzazepine nucleus with the 5-carboxamide substituent, but is structurally different at the 10,11-position. ESL is a pro-drug metab...
Gorde:
| Argitaratua izan da: | Neuropsychiatr Dis Treat |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4889089/ https://ncbi.nlm.nih.gov/pubmed/27307737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S86765 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|